The Blue Pill: An Hazardous Bet?

The story of Viagra and the medicinal industry presents a challenging picture for careful investors. Initially, copyright's blockbuster drug altered the treatment of erectile dysfunction, creating significant profits and defining the modern pharmaceutical landscape. However, exclusive rights expiration and the appearance of alternative versions hav

read more